Acton, MA, United States of America

Frank Eldridge Lovering

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Pfizer Corporation, Wyeth, Genetics Institute, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Eldridge Lovering. Retrieved from https://idiyas.com/inventor/frank-eldridge-lovering

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 70.6

 

 

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 246(Granted Patents)


Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bicyclic-Fused Compounds
Heteroaryl Compounds
Benzimidazole Derivatives
Pyrimidine Carboxamides
IRAK4 Modulators
Beta-Secretase Inhibitors
Phospholipase Inhibitors
Amino-Pyridines
Biaryl Sulfonamides
Hydroxamic Acid Inhibitors
Matrix Metalloproteinase
Azolylacylguanidines
17 patents (USPTO):Explore Patents

Title: Frank Eldridge Lovering: Innovator in Pharmaceutical Compounds

Introduction

Frank Eldridge Lovering is a notable inventor based in Acton, MA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 17 patents. His work primarily focuses on the development of innovative compounds that have therapeutic applications.

Latest Patents

Among his latest patents are those related to bicyclic-fused heteroaryl or aryl compounds. These patents disclose compounds, tautomers, and pharmaceutically acceptable salts of the compounds, which are defined by a specific structure outlined in the specifications. In one embodiment, a pharmaceutical composition can be formulated in a liquid dosage form, containing a therapeutically effective amount of the compound or its pharmaceutically acceptable salt as an adjuvant and therapeutic agent. Additionally, methods of adjuvant treating various disorders or conditions through the administration of these pharmaceutical compositions to patients are also described.

Career Highlights

Throughout his career, Frank has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Wyeth. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Frank has collaborated with several professionals in his field, including Joseph Walter Strohbach and David Hepworth. These collaborations have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Frank Eldridge Lovering's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant innovator. His work continues to influence the development of therapeutic compounds that can improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…